View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsEcofibre 将来の成長Future 基準チェック /06現在、 Ecofibreの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 収益成長49.8%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報お知らせ • Sep 27Ecofibre Limited Provides Earnings Guidance for the Fiscal Year 2023Ecofibre Limited provided earnings guidance for the fiscal year 2023. For the period, the company expects to incur a smaller loss, with a clear pathway to profitability and positive cash flow in fiscal year 2024.Major Estimate Revision • Jun 04Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast fell from AU$57.6m to AU$37.6m. EPS estimate reaffirmed at -AU$0.022 per share. Pharmaceuticals industry in Australia expected to see average net income growth of 18% next year. Consensus price target down from AU$2.39 to AU$1.65. Share price rose 35% to AU$0.74 over the past week.お知らせ • May 06Ecofibre Limited Provides Earnings Guidance for the Second Half of 2021 and Fiscal Year 2021Ecofibre Limited expected to have a loss of around $1.5 million in second half of 2021 resulting in a fiscal year 2021 loss of around $7 million.Major Estimate Revision • Feb 13Analysts lower EPS estimates to -AU$0.022The 2021 consensus revenue estimate was lowered from AU$59.8m to AU$57.6m. The company is forecast to report a loss instead of a profit with analysts lowering their EPS forecasts from AU$0.0037 to -AU$0.022 for the same period. The Pharmaceuticals industry in Australia is expected to see an average net income growth of 18% next year. The consensus price target was lowered from AU$2.26 to AU$1.65. Share price is down by 7.2% to AU$1.60 over the past week.Major Estimate Revision • Oct 22Analysts lower revenue estimates to AU$59.8mThe 2021 consensus revenue estimate decreased from AU$86.7m. Earning per share (EPS) estimate was also lowered from AU$0.045 to AU$0.0037 for the same period. Net income is expected to shrink by 90% next year compared to 22% growth forecast for the Pharmaceuticals industry in Australia . The consensus price target was lowered from AU$3.20 to AU$2.26. Share price is down by 31% to AU$1.78 over the past week.Price Target Changed • Oct 21Price target lowered to AU$2.26Down from AU$3.33, the current price target is provided by 1 analyst. The new target price is 23% above the current share price of AU$1.83. As of last close, the stock is down 43% over the past year.すべての更新を表示Recent updatesお知らせ • Mar 19Ecofibre Limited Announces Chief Financial Officer Changes, Effective March 24, 2025Ecofibre Limited announced the retirement of Jonathan Brown and the appointment of Amy Elizabeth Donley as Chief Financial Officer (CFO) of Ecofibre, effective March 24, 2025. Amy is a dynamic finance leader with a track record of driving successful C-suite financial performance, and developing and implementing commercial strategy and business improvement plans in both large corporate and smaller entrepreneurial companies. She has extensive experience in technical accounting (IFRS and US GAAP), ERP implementations and working within regulated industries. Amy is based in North Carolina and is passionate about sustainability and the opportunities for Ecofibre as the market for sustainable solutions continues to grow. Amy replaces Jonathan Brown as CFO, as Jonathan retires from Ecofibre after many years of service. There will be a one-month transition period.分析記事 • Feb 28Benign Growth For Ecofibre Limited (ASX:EOF) Underpins Stock's 26% PlummetUnfortunately for some shareholders, the Ecofibre Limited ( ASX:EOF ) share price has dived 26% in the last thirty...New Risk • Feb 28New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$15m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 56% per year over the past 5 years. Market cap is less than US$10m (AU$9.17m market cap, or US$5.69m).Reported Earnings • Feb 21First half 2025 earnings releasedFirst half 2025 results: Revenue: AU$12.4m (down 2.5% from 1H 2024). Net loss: AU$6.00m (loss narrowed 87% from 1H 2024).お知らせ • Feb 14Ecofibre Limited to Report First Half, 2025 Results on Feb 19, 2025Ecofibre Limited announced that they will report first half, 2025 results on Feb 19, 2025分析記事 • Dec 02Ecofibre Limited's (ASX:EOF) 30% Dip In Price Shows Sentiment Is Matching RevenuesEcofibre Limited ( ASX:EOF ) shares have retraced a considerable 30% in the last month, reversing a fair amount of...分析記事 • Oct 03Ecofibre Limited's (ASX:EOF) Price Is Right But Growth Is Lacking After Shares Rocket 30%Ecofibre Limited ( ASX:EOF ) shareholders are no doubt pleased to see that the share price has bounced 30% in the last...お知らせ • Sep 02Ecofibre Limited, Annual General Meeting, Oct 16, 2024Ecofibre Limited, Annual General Meeting, Oct 16, 2024.Reported Earnings • Aug 28Full year 2024 earnings released: AU$0.11 loss per share (vs AU$0.12 loss in FY 2023)Full year 2024 results: AU$0.11 loss per share (improved from AU$0.12 loss in FY 2023). Revenue: AU$28.0m (down 14% from FY 2023). Net loss: AU$38.2m (loss narrowed 4.3% from FY 2023). Over the last 3 years on average, the company's earnings growth rate has exceeded its share price growth rate by 3 percentage points per year.分析記事 • Aug 19Ecofibre Limited (ASX:EOF) Not Doing Enough For Some Investors As Its Shares Slump 33%Unfortunately for some shareholders, the Ecofibre Limited ( ASX:EOF ) share price has dived 33% in the last thirty...分析記事 • Jun 20Benign Growth For Ecofibre Limited (ASX:EOF) Underpins Stock's 41% PlummetUnfortunately for some shareholders, the Ecofibre Limited ( ASX:EOF ) share price has dived 41% in the last thirty...New Risk • Jun 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: AU$12.8m (US$8.52m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 71% per year over the past 5 years. Market cap is less than US$10m (AU$12.8m market cap, or US$8.52m). Minor Risk Shareholders have been diluted in the past year (8.9% increase in shares outstanding).分析記事 • Apr 24Ecofibre Limited (ASX:EOF) Might Not Be As Mispriced As It Looks After Plunging 39%Ecofibre Limited ( ASX:EOF ) shareholders that were waiting for something to happen have been dealt a blow with a 39...分析記事 • Apr 13Is Ecofibre (ASX:EOF) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...お知らせ • Mar 28Elixinol Wellness Limited (ASX:EXL) completed the acquisition of Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF).Elixinol Wellness Limited (ASX:EXL) entered into Conditional agreement to acquire Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF) for AUD 3 million on February 12, 2024. Under the terms of agreement, Elixinol Wellness will pay AUD 2 million as upfront payment and AUD 1 million as earnout consideration. Elixinol Wellness Limited will raise AUD 3.16 million through Rights Issue Offer which will be used in part to finance the acquisition. The deal is expected to be completed by the end of March, 2024. Completion of the Ananda Food acquisition is conditional on raising sufficient funds under the Rights Issue Offer and the satisfaction of a number of customary conditions. As of March 20, 2024, the transaction is expected to close on March 28, 2024. Elixinol Wellness Limited (ASX:EXL) completed the acquisition of Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF) on March 28, 2024. Ron Dufficy will now be stepping down from the role of Group Chief Executive Officer and Natalie Butler will join the EXL Board.New Risk • Feb 25New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$6.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$6.9m free cash flow). Earnings have declined by 66% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (8.9% increase in shares outstanding). Market cap is less than US$100m (AU$31.1m market cap, or US$20.4m).分析記事 • Feb 20Lacklustre Performance Is Driving Ecofibre Limited's (ASX:EOF) 28% Price DropThe Ecofibre Limited ( ASX:EOF ) share price has fared very poorly over the last month, falling by a substantial 28...お知らせ • Feb 20Ecofibre Limited to Report First Half, 2024 Results on Feb 23, 2024Ecofibre Limited announced that they will report first half, 2024 results on Feb 23, 2024お知らせ • Feb 14Elixinol Wellness Limited (ASX:EXL) entered into Conditional agreement to acquire Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF) for AUD 3 million.Elixinol Wellness Limited (ASX:EXL) entered into Conditional agreement to acquire Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF) for AUD 3 million on February 12, 2024. The deal is expected to be completed by the end of March, 2024.お知らせ • Jan 30+ 1 more updateEcofibre Limited, Annual General Meeting, Feb 28, 2024Ecofibre Limited, Annual General Meeting, Feb 28, 2024, at 11:01 AUS Eastern Standard Time. Location: at the offices of Colin, Biggers and Paisley, Level 42, 2 Park Street, Sydney Nsw 2000 New South Wales Australia Agenda: To consider appointment of Director.分析記事 • Jan 03Ecofibre Limited's (ASX:EOF) Shares Bounce 30% But Its Business Still Trails The IndustryThose holding Ecofibre Limited ( ASX:EOF ) shares would be relieved that the share price has rebounded 30% in the last...お知らせ • Nov 29+ 1 more updateEcofibre Limited Announces CEO ChangesEcofibre Limited announced that their long-standing CEO, Eric Wang, has tendered his resignation, and the Ecofibre Board has accepted his resignation effective immediately. Eric Wang joined Ecofibre in 2016 as CFO and Executive Director. Vanessa Wallace will act as interim CEO, and Ecofibre will commence a comprehensive search and make further announcements as appropriate.お知らせ • Oct 05Ecofibre Limited, Annual General Meeting, Nov 23, 2023Ecofibre Limited, Annual General Meeting, Nov 23, 2023, at 11:01 AUS Eastern Standard Time.Reported Earnings • Oct 01Full year 2023 earnings released: AU$0.12 loss per share (vs AU$0.044 loss in FY 2022)Full year 2023 results: AU$0.12 loss per share (further deteriorated from AU$0.044 loss in FY 2022). Revenue: AU$32.5m (up 7.6% from FY 2022). Net loss: AU$39.9m (loss widened 172% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance.分析記事 • Sep 29Does Ecofibre (ASX:EOF) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...New Risk • Sep 02New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$8.6m free cash flow). Earnings have declined by 53% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (8.3% increase in shares outstanding). Market cap is less than US$100m (AU$65.4m market cap, or US$42.2m).Reported Earnings • Aug 23Full year 2023 earnings released: AU$0.12 loss per share (vs AU$0.044 loss in FY 2022)Full year 2023 results: AU$0.12 loss per share (further deteriorated from AU$0.044 loss in FY 2022). Revenue: AU$32.5m (up 7.6% from FY 2022). Net loss: AU$39.9m (loss widened 172% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance.お知らせ • Aug 18Ecofibre Limited to Report Fiscal Year 2023 Results on Aug 22, 2023Ecofibre Limited announced that they will report fiscal year 2023 results on Aug 22, 2023New Risk • Aug 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$13m free cash flow). Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (AU$67.1m market cap, or US$44.2m).分析記事 • Jun 22Is Ecofibre (ASX:EOF) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Recent Insider Transactions • Mar 22CEO, MD & Director recently bought AU$58k worth of stockOn the 15th of March, Eric Wang bought around 289k shares on-market at roughly AU$0.20 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Eric has been a buyer over the last 12 months, purchasing a net total of AU$249k worth in shares.Board Change • Feb 22High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. CEO, MD & Director Eric Wang is the most experienced director on the board, commencing their role in 2015. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 21First half 2023 earnings released: AU$0.052 loss per share (vs AU$0.02 loss in 1H 2022)First half 2023 results: AU$0.052 loss per share (further deteriorated from AU$0.02 loss in 1H 2022). Revenue: AU$16.5m (up 6.4% from 1H 2022). Net loss: AU$17.6m (loss widened 163% from 1H 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.お知らせ • Feb 20Jon Meadmore to Retire as A Non-Executive Director of Ecofibre LimitedEcofibre Limited announced that Jon Meadmore will retire as a non-executive director of the company as at the Half Year Results announcement on 20 February 2023. Meadmore has been on the Ecofibre Board since October 2017 and was the company's first non-executive director.お知らせ • Feb 16Ecofibre Limited to Report First Half, 2023 Results on Feb 20, 2023Ecofibre Limited announced that they will report first half, 2023 results on Feb 20, 2023Recent Insider Transactions • Nov 22CEO, MD & Director recently bought AU$58k worth of stockOn the 16th of November, Eric Wang bought around 217k shares on-market at roughly AU$0.27 per share. This transaction amounted to 1.5% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth AU$133k. Eric has been a buyer over the last 12 months, purchasing a net total of AU$626k worth in shares.Recent Insider Transactions • Nov 17CEO, MD & Director recently bought AU$133k worth of stockOn the 10th of November, Eric Wang bought around 588k shares on-market at roughly AU$0.23 per share. This transaction amounted to 4.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Eric has been a buyer over the last 12 months, purchasing a net total of AU$567k worth in shares.分析記事 • Oct 29We Think Ecofibre (ASX:EOF) Has A Fair Chunk Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...お知らせ • Sep 27Ecofibre Limited Provides Earnings Guidance for the Fiscal Year 2023Ecofibre Limited provided earnings guidance for the fiscal year 2023. For the period, the company expects to incur a smaller loss, with a clear pathway to profitability and positive cash flow in fiscal year 2024.お知らせ • Sep 16Ecofibre Limited Launches Green II Gold, a Professional Quality, CBD-Infused Skincare Line for Spas and SalonsEcofibre announced the launch of Green II Gold, an innovative, new CBD-based skincare line. Green II Gold is the first skincare line formulated from the ground up to pair Ananda Professional's clinical strength, full spectrum hemp extract with potent botanical-based ingredients to provide professional-level products for spas and salons. Already the leader in sustainable, hemp-based tinctures, soft gels, fruit chews, and topicals, AnandaProfessional is the preferred CBD choice of over 4,000 independent pharmacies. While many companies repurpose existing tinctures and topicals, Green II Gold is specifically formulated to address the needs of licensed spa and salon professionals and their clients. Green II Gold products are certified cruelty free and vegan while utilizing green chemistry and ethical sourcing that align with Ecofibre's mission to improve the lives of customers as well as genuinely improve all the environments Ecofibre works in. Green II Gold will be available through salons and spas in the United States.お知らせ • Sep 10Ecofibre Limited, Annual General Meeting, Nov 08, 2022Ecofibre Limited, Annual General Meeting, Nov 08, 2022, at 11:00 AUS Eastern Standard Time.Reported Earnings • Aug 23Full year 2022 earnings released: AU$0.044 loss per share (vs AU$0.022 loss in FY 2021)Full year 2022 results: AU$0.044 loss per share (down from AU$0.022 loss in FY 2021). Revenue: AU$30.2m (up 5.0% from FY 2021). Net loss: AU$14.7m (loss widened 110% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.お知らせ • Aug 16Ecofibre Limited to Report Fiscal Year 2022 Results on Aug 22, 2022Ecofibre Limited announced that they will report fiscal year 2022 results on Aug 22, 2022お知らせ • Aug 02Ecofibre Limited Appoints Mark Bayliss as Director, Effective 1 September, 2022Ecofibre Limited announced that Mark Bayliss will be appointed as a new director of the Company, effective 1 September, 2022. Mr. Bayliss is a director and senior executive with extensive experience in a variety of roles across listed and private companies, management buyouts, private equity and turnarounds in Australia, NZ, UK and US. He has been the CEO of three listed companies and one private company and the Chairman of 3 companies and 2 non-for-profits. His industry experience is broad including eCommerce, Technology, Credit Finance, Retail, FMCG, Media & Publishing, Advertising & Marketing Services and Manufacturing.お知らせ • May 31Ecofibre Limited Announces Resignation of Kristi Woolrych as Non-Executive DirectorEcofibre Limited announced that Kristi Woolrych has resigned from the Company's Board, effective immediately. Woolrych joined the Company's Board as a non-executive director in October 2020, a position she held while also acting in a full time executive capacity as Chief Marketing Officer at KFC South Pacific. Ms Woolrych's resignation allows her to focus on a new role leading that business as general manager, KFC South Pacific.お知らせ • Apr 28Ecofibre Limited (ASX:EOF) acquired New Composite Partners for AUD 0.3 million.Ecofibre Limited (ASX:EOF) acquired New Composite Partners for AUD 0.3 million during the third quarter ended March 31, 2022. Ecofibre Limited (ASX:EOF) completed the acquisition of New Composite Partners during the third quarter ended March 31, 2022.お知らせ • Apr 27Ecofibre Limited (ASX:EOF) acquired Soul Seeds for AUD 0.3 million.Ecofibre Limited (ASX:EOF) acquired Soul Seeds for AUD 0.3 million in third quarter, 2021. Ecofibre Limited (ASX:EOF) completed the acquisition of Soul Seeds in third quarter, 2021.Board Change • Apr 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. CEO, MD & Director Eric Wang is the most experienced director on the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Recent Insider Transactions • Mar 09CEO, MD & Director recently bought AU$435k worth of stockOn the 4th of March, Eric Wang bought around 1m shares on-market at roughly AU$0.43 per share. This was the largest purchase by an insider in the last 3 months. This was Eric's only on-market trade for the last 12 months.分析記事 • Mar 05Would Ecofibre (ASX:EOF) Be Better Off With Less Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Board Change • Feb 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. CEO, MD & Director Eric Wang is the most experienced director on the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Aug 04Full year 2021 earnings released: AU$0.022 loss per share (vs AU$0.044 profit in FY 2020)The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: AU$28.8m (down 43% from FY 2020). Net loss: AU$6.99m (down 153% from profit in FY 2020).Major Estimate Revision • Jun 04Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast fell from AU$57.6m to AU$37.6m. EPS estimate reaffirmed at -AU$0.022 per share. Pharmaceuticals industry in Australia expected to see average net income growth of 18% next year. Consensus price target down from AU$2.39 to AU$1.65. Share price rose 35% to AU$0.74 over the past week.分析記事 • Jun 04One Forecaster Is Now More Bearish On Ecofibre Limited (ASX:EOF) Than They Used To BeMarket forces rained on the parade of Ecofibre Limited ( ASX:EOF ) shareholders today, when the covering analyst...お知らせ • May 06Ecofibre Limited Provides Earnings Guidance for the Second Half of 2021 and Fiscal Year 2021Ecofibre Limited expected to have a loss of around $1.5 million in second half of 2021 resulting in a fiscal year 2021 loss of around $7 million.分析記事 • Mar 31Ecofibre (ASX:EOF) Has Debt But No Earnings; Should You Worry?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Mar 05Would Shareholders Who Purchased Ecofibre's (ASX:EOF) Stock Year Be Happy With The Share price Today?The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...お知らせ • Mar 05Ecofibre Limited Appoints Bruce Robinson AC as DirectorEcofibre Limited announced the appointment of Professor Bruce Robinson AC as a director of the Company effective 4 March 2021. Prof. Robinson has over 25 years leadership experience as a board director, academic physician and scientist across research, healthcare and medicine, and tertiary education. He has extensive experience covering academia, government, public and private health providers, research institutes and philanthropic organisations. He is currently a director of Cochlea; MaynePharma. He will be a non-executive Director and is considered by the Board to be independent. As noted by the Company at the 2020 Annual General Meeting, a further significant Director appointment is expected to be announced prior to Mr. Lambert's retirement from the Board later in 2021. 2015 - present he is the Chair of the National Health and Medical Research Council.Major Estimate Revision • Feb 13Analysts lower EPS estimates to -AU$0.022The 2021 consensus revenue estimate was lowered from AU$59.8m to AU$57.6m. The company is forecast to report a loss instead of a profit with analysts lowering their EPS forecasts from AU$0.0037 to -AU$0.022 for the same period. The Pharmaceuticals industry in Australia is expected to see an average net income growth of 18% next year. The consensus price target was lowered from AU$2.26 to AU$1.65. Share price is down by 7.2% to AU$1.60 over the past week.Is New 90 Day High Low • Feb 12New 90-day low: AU$1.60The company is down 1.0% from its price of AU$1.62 on 13 November 2020. The Australian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 30% over the same period.分析記事 • Feb 07We Wouldn't Rely On Ecofibre's (ASX:EOF) Statutory Earnings As A GuideBroadly speaking, profitable businesses are less risky than unprofitable ones. However, sometimes companies receive a...お知らせ • Jan 22Ecofibre Limited Appoints Ms. Robin Sheldon as General Counsel and Joint Company SecretaryEcofibre Limited announced that Ms. Robin Sheldon has been appointed as General Counsel and Joint Company Secretary of Ecofibre. Ms. Sheldon will be a joint Company Secretary with Mr. Jonathan Brown, the current Company Secretary and Chief Financial Officer of Ecofibre. Pursuant to Listing Rule 12.6, Mr. Brown will remain responsible for communication with the ASX in relation to listing rule matters. Ms. Sheldon has 29 years experience in corporate law. Prior to joining Ecofibre, Ms. Sheldon was employed by Thomas Jefferson University as Sr, VP of Jefferson Strategic Ventures, VP of its Innovation Pillar and Associate Counsel.お知らせ • Jan 20Ecofibre Limited Enters into an Exclusive Distribution Agreement with MEDISCAEcofibre Limited announced that the Company has entered into an exclusive distribution agreement with MEDISCA. Under this agreement, in the US, Canada and Australia, MEDISCA is the exclusive compounding pharmacy distributor for Ananda Health products and Ananda Health is the exclusive CBD finished product to be distributed by MEDISCA. Key terms of this agreement: Term 3 years, plus 2-year options to extend; Exclusive regions are United States, Canada and Australia. MEDISCA can distribute to other geographies on a non-exclusive basis; Ananda Health is the exclusive provider of all CBD finished products; Product range for MEDISCA includes all Ananda Health products to include ingestibles, topicals, women's health and diabetic health; Minimum sales requirements will be established six months from contract start date.分析記事 • Jan 04What You Need To Know About Ecofibre Limited's (ASX:EOF) Investor CompositionA look at the shareholders of Ecofibre Limited ( ASX:EOF ) can tell us which group is most powerful. Institutions will...Recent Insider Transactions • Dec 18CEO, MD & Director recently bought AU$745k worth of stockOn the 11th of December, Eric Wang bought around 350k shares on-market at roughly AU$2.13 per share. This was the largest purchase by an insider in the last 3 months. This was Eric's only on-market trade for the last 12 months.分析記事 • Dec 14Should You Be Excited About Ecofibre Limited's (ASX:EOF) 21% Return On Equity?One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...Valuation Update With 7 Day Price Move • Dec 03Market bids up stock over the past weekAfter last week's 16% share price gain to AU$2.00, the stock is trading at a trailing P/E ratio of 45.1x, up from the previous P/E ratio of 38.8x. This compares to an average P/E of 44x in the Pharmaceuticals industry in Oceania. Total return to shareholders over the past year is a loss of 36%.分析記事 • Nov 26Ecofibre's (ASX:EOF) Stock Price Has Reduced 49% In The Past YearPassive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if...Major Estimate Revision • Oct 22Analysts lower revenue estimates to AU$59.8mThe 2021 consensus revenue estimate decreased from AU$86.7m. Earning per share (EPS) estimate was also lowered from AU$0.045 to AU$0.0037 for the same period. Net income is expected to shrink by 90% next year compared to 22% growth forecast for the Pharmaceuticals industry in Australia . The consensus price target was lowered from AU$3.20 to AU$2.26. Share price is down by 31% to AU$1.78 over the past week.Price Target Changed • Oct 21Price target lowered to AU$2.26Down from AU$3.33, the current price target is provided by 1 analyst. The new target price is 23% above the current share price of AU$1.83. As of last close, the stock is down 43% over the past year.お知らせ • Oct 20Ecofibre Limited Appoints Kristi Woolrych as Independent Non-Executive DirectorEcofibre Limited announced the appointment of Ms. Kristi Woolrych as an independent non-executive director of the Company effective 20 October 2020. Ms Woolrych has over 20 years' experience in brand strategy, acquisition, retention, customer experience, eCommerce and retail marketing. She is currently the Chief Marketing Officer for KFC in Australia and New Zealand with accountability for sales growth, eCommerce and overall brand performance. In accordance with Ecofibre's Constitution, Ms Woolrych will be presented to shareholders for election at Ecofibre's 2020 annual general meeting on 25 November 2020.Valuation Update With 7 Day Price Move • Oct 20Market pulls back on stock over the past weekAfter last week's 29% share price decline to AU$1.81, the stock is trading at a trailing P/E ratio of 40.9x, down from the previous P/E ratio of 57.6x. This compares to an average P/E of 49x in the Pharmaceuticals industry in Oceania. Total return to shareholders over the past year is a loss of 45%.Is New 90 Day High Low • Oct 20New 90-day low: AU$1.81The company is down 26% from its price of AU$2.45 on 22 July 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is down 1.0% over the same period.お知らせ • Aug 25Ecofibre Limited (ASX:EOF) completed the acquisition of portfolio of businesses and assets of TexInnovate, Inc.Ecofibre Limited (ASX:EOF) entered into an asset sale agreement to acquire portfolio of businesses and assets of TexInnovate, Inc. for $42 million on July 29, 2020. Out of the total consideration, $21 million will be paid at completion and remaining $21 million will paid as earn out in three equal tranches on third, fourth and fifth anniversaries after completion. Each such payment will consist of 50% cash and 50% Ecofibre shares at the scrip value. Earn out is subject to the acquired businesses delivering $6 million EBIT for two consecutive annual periods. Portfolio of businesses and assets of TexInnovate, Inc. is consists of Triad Polymers, Trident Fibers, Fibex, Knitmasters and business of TexInnovate. To fund the cash component payable at completion, Ecofibre has conducted a placement under its Listing Rule 7.1 capacity to existing institutional shareholders of $29.5 million in aggregate at an issue price of $2.50. Ecofibre intends to employ all of TexInnovate’s staff at completion. Transaction is subject to satisfactory due diligence by Ecofibre over a 30-day period. The due diligence period is completed on August 21, 2020. Transaction is expected to close on September 1, 2020. Ecofibre Limited (ASX:EOF) completed the acquisition of portfolio of businesses and assets of TexInnovate, Inc. on August 21, 2020. Ecofibre Limited issued 5.9 million shares for the consideration on August 24, 2020 and will issue 5.9 million shares for earn-out payment as well. The Initial consideration shares expected to commence trading on August 26, 2020. Jeff Bruner and his team will be part of the Ecofibre family.お知らせ • Jul 31Ecofibre Limited (ASX:EOF) entered into an asset sale agreement to acquire Portfolio of businesses and assets of TexInnovate, Inc. for $42 million.Ecofibre Limited (ASX:EOF) entered into an asset sale agreement to acquire Portfolio of businesses and assets of TexInnovate, Inc. for $42 million on July 29, 2020. Out of the total consideration, $21 million will be paid at completion, remaining $21 million will paid as earn out in three equal tranches on third, fourth and fifth anniversaries after completion. Each such payment will consist of 50% cash and 50% Ecofibre shares at the Scrip Value. Earn out is subject to the acquired businesses delivering $6 million EBIT for two consecutive annual periods. Portfolio of businesses and assets of TexInnovate, Inc. is consists of Triad Polymers, Trident Fibers, Fibex, Knitmasters and business of TexInnovate. To fund the cash component payable at completion, Ecofibre has conducted a placement under its Listing Rule 7.1 capacity to existing institutional shareholders of $29.5 million in aggregate at an issue price of $2.50. Ecofibre intends to employ all of TexInnovate’s staff at completion. Transaction is subject to satisfactory due diligence by Ecofibre over a 30-day period. Transaction is expected to close on September 1, 2020. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Ecofibre は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測ASX:EOF - アナリストの将来予測と過去の財務データ ( )AUD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202428-15-15-14N/A9/30/202428-29-16-14N/A6/30/202428-43-17-14N/A3/31/202427-54-15-11N/A12/31/202327-66-12-9N/A9/30/202329-52-10-8N/A6/30/202331-38-9-7N/A3/31/202330-31-11-9N/A12/31/202230-24-13-11N/A9/30/202230-20-13-11N/A6/30/202230-15-13-11N/A3/31/202230-11-12-9N/A12/31/202130-8-11-8N/A9/30/202129-8-13-8N/A6/30/202129-7-14-8N/A3/31/202133-3-19-6N/A12/31/2020361-24-4N/A9/30/2020447-211N/A6/30/20205113-176N/A3/31/20205113-106N/A12/31/20195113-37N/A9/30/20194310-35N/A6/30/2019366-32N/A3/31/2019270-50N/A12/31/201818-7-7-3N/A9/30/201812-8N/A-5N/A6/30/20186-9N/A-7N/A6/30/20171-9N/A-7N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: EOFの予測収益成長が 貯蓄率 ( 3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: EOFの収益がAustralian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: EOFの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: EOFの収益がAustralian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: EOFの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: EOFの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/07/29 20:58終値2025/05/01 00:00収益2024/12/31年間収益2024/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ecofibre Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関William MacdiarmidOrd Minnett LimitedAlexander SmithPAC Partners Securities Pty. Ltd.
お知らせ • Sep 27Ecofibre Limited Provides Earnings Guidance for the Fiscal Year 2023Ecofibre Limited provided earnings guidance for the fiscal year 2023. For the period, the company expects to incur a smaller loss, with a clear pathway to profitability and positive cash flow in fiscal year 2024.
Major Estimate Revision • Jun 04Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast fell from AU$57.6m to AU$37.6m. EPS estimate reaffirmed at -AU$0.022 per share. Pharmaceuticals industry in Australia expected to see average net income growth of 18% next year. Consensus price target down from AU$2.39 to AU$1.65. Share price rose 35% to AU$0.74 over the past week.
お知らせ • May 06Ecofibre Limited Provides Earnings Guidance for the Second Half of 2021 and Fiscal Year 2021Ecofibre Limited expected to have a loss of around $1.5 million in second half of 2021 resulting in a fiscal year 2021 loss of around $7 million.
Major Estimate Revision • Feb 13Analysts lower EPS estimates to -AU$0.022The 2021 consensus revenue estimate was lowered from AU$59.8m to AU$57.6m. The company is forecast to report a loss instead of a profit with analysts lowering their EPS forecasts from AU$0.0037 to -AU$0.022 for the same period. The Pharmaceuticals industry in Australia is expected to see an average net income growth of 18% next year. The consensus price target was lowered from AU$2.26 to AU$1.65. Share price is down by 7.2% to AU$1.60 over the past week.
Major Estimate Revision • Oct 22Analysts lower revenue estimates to AU$59.8mThe 2021 consensus revenue estimate decreased from AU$86.7m. Earning per share (EPS) estimate was also lowered from AU$0.045 to AU$0.0037 for the same period. Net income is expected to shrink by 90% next year compared to 22% growth forecast for the Pharmaceuticals industry in Australia . The consensus price target was lowered from AU$3.20 to AU$2.26. Share price is down by 31% to AU$1.78 over the past week.
Price Target Changed • Oct 21Price target lowered to AU$2.26Down from AU$3.33, the current price target is provided by 1 analyst. The new target price is 23% above the current share price of AU$1.83. As of last close, the stock is down 43% over the past year.
お知らせ • Mar 19Ecofibre Limited Announces Chief Financial Officer Changes, Effective March 24, 2025Ecofibre Limited announced the retirement of Jonathan Brown and the appointment of Amy Elizabeth Donley as Chief Financial Officer (CFO) of Ecofibre, effective March 24, 2025. Amy is a dynamic finance leader with a track record of driving successful C-suite financial performance, and developing and implementing commercial strategy and business improvement plans in both large corporate and smaller entrepreneurial companies. She has extensive experience in technical accounting (IFRS and US GAAP), ERP implementations and working within regulated industries. Amy is based in North Carolina and is passionate about sustainability and the opportunities for Ecofibre as the market for sustainable solutions continues to grow. Amy replaces Jonathan Brown as CFO, as Jonathan retires from Ecofibre after many years of service. There will be a one-month transition period.
分析記事 • Feb 28Benign Growth For Ecofibre Limited (ASX:EOF) Underpins Stock's 26% PlummetUnfortunately for some shareholders, the Ecofibre Limited ( ASX:EOF ) share price has dived 26% in the last thirty...
New Risk • Feb 28New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$15m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 56% per year over the past 5 years. Market cap is less than US$10m (AU$9.17m market cap, or US$5.69m).
Reported Earnings • Feb 21First half 2025 earnings releasedFirst half 2025 results: Revenue: AU$12.4m (down 2.5% from 1H 2024). Net loss: AU$6.00m (loss narrowed 87% from 1H 2024).
お知らせ • Feb 14Ecofibre Limited to Report First Half, 2025 Results on Feb 19, 2025Ecofibre Limited announced that they will report first half, 2025 results on Feb 19, 2025
分析記事 • Dec 02Ecofibre Limited's (ASX:EOF) 30% Dip In Price Shows Sentiment Is Matching RevenuesEcofibre Limited ( ASX:EOF ) shares have retraced a considerable 30% in the last month, reversing a fair amount of...
分析記事 • Oct 03Ecofibre Limited's (ASX:EOF) Price Is Right But Growth Is Lacking After Shares Rocket 30%Ecofibre Limited ( ASX:EOF ) shareholders are no doubt pleased to see that the share price has bounced 30% in the last...
お知らせ • Sep 02Ecofibre Limited, Annual General Meeting, Oct 16, 2024Ecofibre Limited, Annual General Meeting, Oct 16, 2024.
Reported Earnings • Aug 28Full year 2024 earnings released: AU$0.11 loss per share (vs AU$0.12 loss in FY 2023)Full year 2024 results: AU$0.11 loss per share (improved from AU$0.12 loss in FY 2023). Revenue: AU$28.0m (down 14% from FY 2023). Net loss: AU$38.2m (loss narrowed 4.3% from FY 2023). Over the last 3 years on average, the company's earnings growth rate has exceeded its share price growth rate by 3 percentage points per year.
分析記事 • Aug 19Ecofibre Limited (ASX:EOF) Not Doing Enough For Some Investors As Its Shares Slump 33%Unfortunately for some shareholders, the Ecofibre Limited ( ASX:EOF ) share price has dived 33% in the last thirty...
分析記事 • Jun 20Benign Growth For Ecofibre Limited (ASX:EOF) Underpins Stock's 41% PlummetUnfortunately for some shareholders, the Ecofibre Limited ( ASX:EOF ) share price has dived 41% in the last thirty...
New Risk • Jun 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: AU$12.8m (US$8.52m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 71% per year over the past 5 years. Market cap is less than US$10m (AU$12.8m market cap, or US$8.52m). Minor Risk Shareholders have been diluted in the past year (8.9% increase in shares outstanding).
分析記事 • Apr 24Ecofibre Limited (ASX:EOF) Might Not Be As Mispriced As It Looks After Plunging 39%Ecofibre Limited ( ASX:EOF ) shareholders that were waiting for something to happen have been dealt a blow with a 39...
分析記事 • Apr 13Is Ecofibre (ASX:EOF) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
お知らせ • Mar 28Elixinol Wellness Limited (ASX:EXL) completed the acquisition of Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF).Elixinol Wellness Limited (ASX:EXL) entered into Conditional agreement to acquire Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF) for AUD 3 million on February 12, 2024. Under the terms of agreement, Elixinol Wellness will pay AUD 2 million as upfront payment and AUD 1 million as earnout consideration. Elixinol Wellness Limited will raise AUD 3.16 million through Rights Issue Offer which will be used in part to finance the acquisition. The deal is expected to be completed by the end of March, 2024. Completion of the Ananda Food acquisition is conditional on raising sufficient funds under the Rights Issue Offer and the satisfaction of a number of customary conditions. As of March 20, 2024, the transaction is expected to close on March 28, 2024. Elixinol Wellness Limited (ASX:EXL) completed the acquisition of Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF) on March 28, 2024. Ron Dufficy will now be stepping down from the role of Group Chief Executive Officer and Natalie Butler will join the EXL Board.
New Risk • Feb 25New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$6.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$6.9m free cash flow). Earnings have declined by 66% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (8.9% increase in shares outstanding). Market cap is less than US$100m (AU$31.1m market cap, or US$20.4m).
分析記事 • Feb 20Lacklustre Performance Is Driving Ecofibre Limited's (ASX:EOF) 28% Price DropThe Ecofibre Limited ( ASX:EOF ) share price has fared very poorly over the last month, falling by a substantial 28...
お知らせ • Feb 20Ecofibre Limited to Report First Half, 2024 Results on Feb 23, 2024Ecofibre Limited announced that they will report first half, 2024 results on Feb 23, 2024
お知らせ • Feb 14Elixinol Wellness Limited (ASX:EXL) entered into Conditional agreement to acquire Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF) for AUD 3 million.Elixinol Wellness Limited (ASX:EXL) entered into Conditional agreement to acquire Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF) for AUD 3 million on February 12, 2024. The deal is expected to be completed by the end of March, 2024.
お知らせ • Jan 30+ 1 more updateEcofibre Limited, Annual General Meeting, Feb 28, 2024Ecofibre Limited, Annual General Meeting, Feb 28, 2024, at 11:01 AUS Eastern Standard Time. Location: at the offices of Colin, Biggers and Paisley, Level 42, 2 Park Street, Sydney Nsw 2000 New South Wales Australia Agenda: To consider appointment of Director.
分析記事 • Jan 03Ecofibre Limited's (ASX:EOF) Shares Bounce 30% But Its Business Still Trails The IndustryThose holding Ecofibre Limited ( ASX:EOF ) shares would be relieved that the share price has rebounded 30% in the last...
お知らせ • Nov 29+ 1 more updateEcofibre Limited Announces CEO ChangesEcofibre Limited announced that their long-standing CEO, Eric Wang, has tendered his resignation, and the Ecofibre Board has accepted his resignation effective immediately. Eric Wang joined Ecofibre in 2016 as CFO and Executive Director. Vanessa Wallace will act as interim CEO, and Ecofibre will commence a comprehensive search and make further announcements as appropriate.
お知らせ • Oct 05Ecofibre Limited, Annual General Meeting, Nov 23, 2023Ecofibre Limited, Annual General Meeting, Nov 23, 2023, at 11:01 AUS Eastern Standard Time.
Reported Earnings • Oct 01Full year 2023 earnings released: AU$0.12 loss per share (vs AU$0.044 loss in FY 2022)Full year 2023 results: AU$0.12 loss per share (further deteriorated from AU$0.044 loss in FY 2022). Revenue: AU$32.5m (up 7.6% from FY 2022). Net loss: AU$39.9m (loss widened 172% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance.
分析記事 • Sep 29Does Ecofibre (ASX:EOF) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
New Risk • Sep 02New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$8.6m free cash flow). Earnings have declined by 53% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (8.3% increase in shares outstanding). Market cap is less than US$100m (AU$65.4m market cap, or US$42.2m).
Reported Earnings • Aug 23Full year 2023 earnings released: AU$0.12 loss per share (vs AU$0.044 loss in FY 2022)Full year 2023 results: AU$0.12 loss per share (further deteriorated from AU$0.044 loss in FY 2022). Revenue: AU$32.5m (up 7.6% from FY 2022). Net loss: AU$39.9m (loss widened 172% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 18Ecofibre Limited to Report Fiscal Year 2023 Results on Aug 22, 2023Ecofibre Limited announced that they will report fiscal year 2023 results on Aug 22, 2023
New Risk • Aug 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$13m free cash flow). Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (AU$67.1m market cap, or US$44.2m).
分析記事 • Jun 22Is Ecofibre (ASX:EOF) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Recent Insider Transactions • Mar 22CEO, MD & Director recently bought AU$58k worth of stockOn the 15th of March, Eric Wang bought around 289k shares on-market at roughly AU$0.20 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Eric has been a buyer over the last 12 months, purchasing a net total of AU$249k worth in shares.
Board Change • Feb 22High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. CEO, MD & Director Eric Wang is the most experienced director on the board, commencing their role in 2015. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 21First half 2023 earnings released: AU$0.052 loss per share (vs AU$0.02 loss in 1H 2022)First half 2023 results: AU$0.052 loss per share (further deteriorated from AU$0.02 loss in 1H 2022). Revenue: AU$16.5m (up 6.4% from 1H 2022). Net loss: AU$17.6m (loss widened 163% from 1H 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 20Jon Meadmore to Retire as A Non-Executive Director of Ecofibre LimitedEcofibre Limited announced that Jon Meadmore will retire as a non-executive director of the company as at the Half Year Results announcement on 20 February 2023. Meadmore has been on the Ecofibre Board since October 2017 and was the company's first non-executive director.
お知らせ • Feb 16Ecofibre Limited to Report First Half, 2023 Results on Feb 20, 2023Ecofibre Limited announced that they will report first half, 2023 results on Feb 20, 2023
Recent Insider Transactions • Nov 22CEO, MD & Director recently bought AU$58k worth of stockOn the 16th of November, Eric Wang bought around 217k shares on-market at roughly AU$0.27 per share. This transaction amounted to 1.5% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth AU$133k. Eric has been a buyer over the last 12 months, purchasing a net total of AU$626k worth in shares.
Recent Insider Transactions • Nov 17CEO, MD & Director recently bought AU$133k worth of stockOn the 10th of November, Eric Wang bought around 588k shares on-market at roughly AU$0.23 per share. This transaction amounted to 4.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Eric has been a buyer over the last 12 months, purchasing a net total of AU$567k worth in shares.
分析記事 • Oct 29We Think Ecofibre (ASX:EOF) Has A Fair Chunk Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
お知らせ • Sep 27Ecofibre Limited Provides Earnings Guidance for the Fiscal Year 2023Ecofibre Limited provided earnings guidance for the fiscal year 2023. For the period, the company expects to incur a smaller loss, with a clear pathway to profitability and positive cash flow in fiscal year 2024.
お知らせ • Sep 16Ecofibre Limited Launches Green II Gold, a Professional Quality, CBD-Infused Skincare Line for Spas and SalonsEcofibre announced the launch of Green II Gold, an innovative, new CBD-based skincare line. Green II Gold is the first skincare line formulated from the ground up to pair Ananda Professional's clinical strength, full spectrum hemp extract with potent botanical-based ingredients to provide professional-level products for spas and salons. Already the leader in sustainable, hemp-based tinctures, soft gels, fruit chews, and topicals, AnandaProfessional is the preferred CBD choice of over 4,000 independent pharmacies. While many companies repurpose existing tinctures and topicals, Green II Gold is specifically formulated to address the needs of licensed spa and salon professionals and their clients. Green II Gold products are certified cruelty free and vegan while utilizing green chemistry and ethical sourcing that align with Ecofibre's mission to improve the lives of customers as well as genuinely improve all the environments Ecofibre works in. Green II Gold will be available through salons and spas in the United States.
お知らせ • Sep 10Ecofibre Limited, Annual General Meeting, Nov 08, 2022Ecofibre Limited, Annual General Meeting, Nov 08, 2022, at 11:00 AUS Eastern Standard Time.
Reported Earnings • Aug 23Full year 2022 earnings released: AU$0.044 loss per share (vs AU$0.022 loss in FY 2021)Full year 2022 results: AU$0.044 loss per share (down from AU$0.022 loss in FY 2021). Revenue: AU$30.2m (up 5.0% from FY 2021). Net loss: AU$14.7m (loss widened 110% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 16Ecofibre Limited to Report Fiscal Year 2022 Results on Aug 22, 2022Ecofibre Limited announced that they will report fiscal year 2022 results on Aug 22, 2022
お知らせ • Aug 02Ecofibre Limited Appoints Mark Bayliss as Director, Effective 1 September, 2022Ecofibre Limited announced that Mark Bayliss will be appointed as a new director of the Company, effective 1 September, 2022. Mr. Bayliss is a director and senior executive with extensive experience in a variety of roles across listed and private companies, management buyouts, private equity and turnarounds in Australia, NZ, UK and US. He has been the CEO of three listed companies and one private company and the Chairman of 3 companies and 2 non-for-profits. His industry experience is broad including eCommerce, Technology, Credit Finance, Retail, FMCG, Media & Publishing, Advertising & Marketing Services and Manufacturing.
お知らせ • May 31Ecofibre Limited Announces Resignation of Kristi Woolrych as Non-Executive DirectorEcofibre Limited announced that Kristi Woolrych has resigned from the Company's Board, effective immediately. Woolrych joined the Company's Board as a non-executive director in October 2020, a position she held while also acting in a full time executive capacity as Chief Marketing Officer at KFC South Pacific. Ms Woolrych's resignation allows her to focus on a new role leading that business as general manager, KFC South Pacific.
お知らせ • Apr 28Ecofibre Limited (ASX:EOF) acquired New Composite Partners for AUD 0.3 million.Ecofibre Limited (ASX:EOF) acquired New Composite Partners for AUD 0.3 million during the third quarter ended March 31, 2022. Ecofibre Limited (ASX:EOF) completed the acquisition of New Composite Partners during the third quarter ended March 31, 2022.
お知らせ • Apr 27Ecofibre Limited (ASX:EOF) acquired Soul Seeds for AUD 0.3 million.Ecofibre Limited (ASX:EOF) acquired Soul Seeds for AUD 0.3 million in third quarter, 2021. Ecofibre Limited (ASX:EOF) completed the acquisition of Soul Seeds in third quarter, 2021.
Board Change • Apr 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. CEO, MD & Director Eric Wang is the most experienced director on the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Recent Insider Transactions • Mar 09CEO, MD & Director recently bought AU$435k worth of stockOn the 4th of March, Eric Wang bought around 1m shares on-market at roughly AU$0.43 per share. This was the largest purchase by an insider in the last 3 months. This was Eric's only on-market trade for the last 12 months.
分析記事 • Mar 05Would Ecofibre (ASX:EOF) Be Better Off With Less Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Board Change • Feb 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. CEO, MD & Director Eric Wang is the most experienced director on the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Aug 04Full year 2021 earnings released: AU$0.022 loss per share (vs AU$0.044 profit in FY 2020)The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: AU$28.8m (down 43% from FY 2020). Net loss: AU$6.99m (down 153% from profit in FY 2020).
Major Estimate Revision • Jun 04Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast fell from AU$57.6m to AU$37.6m. EPS estimate reaffirmed at -AU$0.022 per share. Pharmaceuticals industry in Australia expected to see average net income growth of 18% next year. Consensus price target down from AU$2.39 to AU$1.65. Share price rose 35% to AU$0.74 over the past week.
分析記事 • Jun 04One Forecaster Is Now More Bearish On Ecofibre Limited (ASX:EOF) Than They Used To BeMarket forces rained on the parade of Ecofibre Limited ( ASX:EOF ) shareholders today, when the covering analyst...
お知らせ • May 06Ecofibre Limited Provides Earnings Guidance for the Second Half of 2021 and Fiscal Year 2021Ecofibre Limited expected to have a loss of around $1.5 million in second half of 2021 resulting in a fiscal year 2021 loss of around $7 million.
分析記事 • Mar 31Ecofibre (ASX:EOF) Has Debt But No Earnings; Should You Worry?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 • Mar 05Would Shareholders Who Purchased Ecofibre's (ASX:EOF) Stock Year Be Happy With The Share price Today?The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...
お知らせ • Mar 05Ecofibre Limited Appoints Bruce Robinson AC as DirectorEcofibre Limited announced the appointment of Professor Bruce Robinson AC as a director of the Company effective 4 March 2021. Prof. Robinson has over 25 years leadership experience as a board director, academic physician and scientist across research, healthcare and medicine, and tertiary education. He has extensive experience covering academia, government, public and private health providers, research institutes and philanthropic organisations. He is currently a director of Cochlea; MaynePharma. He will be a non-executive Director and is considered by the Board to be independent. As noted by the Company at the 2020 Annual General Meeting, a further significant Director appointment is expected to be announced prior to Mr. Lambert's retirement from the Board later in 2021. 2015 - present he is the Chair of the National Health and Medical Research Council.
Major Estimate Revision • Feb 13Analysts lower EPS estimates to -AU$0.022The 2021 consensus revenue estimate was lowered from AU$59.8m to AU$57.6m. The company is forecast to report a loss instead of a profit with analysts lowering their EPS forecasts from AU$0.0037 to -AU$0.022 for the same period. The Pharmaceuticals industry in Australia is expected to see an average net income growth of 18% next year. The consensus price target was lowered from AU$2.26 to AU$1.65. Share price is down by 7.2% to AU$1.60 over the past week.
Is New 90 Day High Low • Feb 12New 90-day low: AU$1.60The company is down 1.0% from its price of AU$1.62 on 13 November 2020. The Australian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 30% over the same period.
分析記事 • Feb 07We Wouldn't Rely On Ecofibre's (ASX:EOF) Statutory Earnings As A GuideBroadly speaking, profitable businesses are less risky than unprofitable ones. However, sometimes companies receive a...
お知らせ • Jan 22Ecofibre Limited Appoints Ms. Robin Sheldon as General Counsel and Joint Company SecretaryEcofibre Limited announced that Ms. Robin Sheldon has been appointed as General Counsel and Joint Company Secretary of Ecofibre. Ms. Sheldon will be a joint Company Secretary with Mr. Jonathan Brown, the current Company Secretary and Chief Financial Officer of Ecofibre. Pursuant to Listing Rule 12.6, Mr. Brown will remain responsible for communication with the ASX in relation to listing rule matters. Ms. Sheldon has 29 years experience in corporate law. Prior to joining Ecofibre, Ms. Sheldon was employed by Thomas Jefferson University as Sr, VP of Jefferson Strategic Ventures, VP of its Innovation Pillar and Associate Counsel.
お知らせ • Jan 20Ecofibre Limited Enters into an Exclusive Distribution Agreement with MEDISCAEcofibre Limited announced that the Company has entered into an exclusive distribution agreement with MEDISCA. Under this agreement, in the US, Canada and Australia, MEDISCA is the exclusive compounding pharmacy distributor for Ananda Health products and Ananda Health is the exclusive CBD finished product to be distributed by MEDISCA. Key terms of this agreement: Term 3 years, plus 2-year options to extend; Exclusive regions are United States, Canada and Australia. MEDISCA can distribute to other geographies on a non-exclusive basis; Ananda Health is the exclusive provider of all CBD finished products; Product range for MEDISCA includes all Ananda Health products to include ingestibles, topicals, women's health and diabetic health; Minimum sales requirements will be established six months from contract start date.
分析記事 • Jan 04What You Need To Know About Ecofibre Limited's (ASX:EOF) Investor CompositionA look at the shareholders of Ecofibre Limited ( ASX:EOF ) can tell us which group is most powerful. Institutions will...
Recent Insider Transactions • Dec 18CEO, MD & Director recently bought AU$745k worth of stockOn the 11th of December, Eric Wang bought around 350k shares on-market at roughly AU$2.13 per share. This was the largest purchase by an insider in the last 3 months. This was Eric's only on-market trade for the last 12 months.
分析記事 • Dec 14Should You Be Excited About Ecofibre Limited's (ASX:EOF) 21% Return On Equity?One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Valuation Update With 7 Day Price Move • Dec 03Market bids up stock over the past weekAfter last week's 16% share price gain to AU$2.00, the stock is trading at a trailing P/E ratio of 45.1x, up from the previous P/E ratio of 38.8x. This compares to an average P/E of 44x in the Pharmaceuticals industry in Oceania. Total return to shareholders over the past year is a loss of 36%.
分析記事 • Nov 26Ecofibre's (ASX:EOF) Stock Price Has Reduced 49% In The Past YearPassive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if...
Major Estimate Revision • Oct 22Analysts lower revenue estimates to AU$59.8mThe 2021 consensus revenue estimate decreased from AU$86.7m. Earning per share (EPS) estimate was also lowered from AU$0.045 to AU$0.0037 for the same period. Net income is expected to shrink by 90% next year compared to 22% growth forecast for the Pharmaceuticals industry in Australia . The consensus price target was lowered from AU$3.20 to AU$2.26. Share price is down by 31% to AU$1.78 over the past week.
Price Target Changed • Oct 21Price target lowered to AU$2.26Down from AU$3.33, the current price target is provided by 1 analyst. The new target price is 23% above the current share price of AU$1.83. As of last close, the stock is down 43% over the past year.
お知らせ • Oct 20Ecofibre Limited Appoints Kristi Woolrych as Independent Non-Executive DirectorEcofibre Limited announced the appointment of Ms. Kristi Woolrych as an independent non-executive director of the Company effective 20 October 2020. Ms Woolrych has over 20 years' experience in brand strategy, acquisition, retention, customer experience, eCommerce and retail marketing. She is currently the Chief Marketing Officer for KFC in Australia and New Zealand with accountability for sales growth, eCommerce and overall brand performance. In accordance with Ecofibre's Constitution, Ms Woolrych will be presented to shareholders for election at Ecofibre's 2020 annual general meeting on 25 November 2020.
Valuation Update With 7 Day Price Move • Oct 20Market pulls back on stock over the past weekAfter last week's 29% share price decline to AU$1.81, the stock is trading at a trailing P/E ratio of 40.9x, down from the previous P/E ratio of 57.6x. This compares to an average P/E of 49x in the Pharmaceuticals industry in Oceania. Total return to shareholders over the past year is a loss of 45%.
Is New 90 Day High Low • Oct 20New 90-day low: AU$1.81The company is down 26% from its price of AU$2.45 on 22 July 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is down 1.0% over the same period.
お知らせ • Aug 25Ecofibre Limited (ASX:EOF) completed the acquisition of portfolio of businesses and assets of TexInnovate, Inc.Ecofibre Limited (ASX:EOF) entered into an asset sale agreement to acquire portfolio of businesses and assets of TexInnovate, Inc. for $42 million on July 29, 2020. Out of the total consideration, $21 million will be paid at completion and remaining $21 million will paid as earn out in three equal tranches on third, fourth and fifth anniversaries after completion. Each such payment will consist of 50% cash and 50% Ecofibre shares at the scrip value. Earn out is subject to the acquired businesses delivering $6 million EBIT for two consecutive annual periods. Portfolio of businesses and assets of TexInnovate, Inc. is consists of Triad Polymers, Trident Fibers, Fibex, Knitmasters and business of TexInnovate. To fund the cash component payable at completion, Ecofibre has conducted a placement under its Listing Rule 7.1 capacity to existing institutional shareholders of $29.5 million in aggregate at an issue price of $2.50. Ecofibre intends to employ all of TexInnovate’s staff at completion. Transaction is subject to satisfactory due diligence by Ecofibre over a 30-day period. The due diligence period is completed on August 21, 2020. Transaction is expected to close on September 1, 2020. Ecofibre Limited (ASX:EOF) completed the acquisition of portfolio of businesses and assets of TexInnovate, Inc. on August 21, 2020. Ecofibre Limited issued 5.9 million shares for the consideration on August 24, 2020 and will issue 5.9 million shares for earn-out payment as well. The Initial consideration shares expected to commence trading on August 26, 2020. Jeff Bruner and his team will be part of the Ecofibre family.
お知らせ • Jul 31Ecofibre Limited (ASX:EOF) entered into an asset sale agreement to acquire Portfolio of businesses and assets of TexInnovate, Inc. for $42 million.Ecofibre Limited (ASX:EOF) entered into an asset sale agreement to acquire Portfolio of businesses and assets of TexInnovate, Inc. for $42 million on July 29, 2020. Out of the total consideration, $21 million will be paid at completion, remaining $21 million will paid as earn out in three equal tranches on third, fourth and fifth anniversaries after completion. Each such payment will consist of 50% cash and 50% Ecofibre shares at the Scrip Value. Earn out is subject to the acquired businesses delivering $6 million EBIT for two consecutive annual periods. Portfolio of businesses and assets of TexInnovate, Inc. is consists of Triad Polymers, Trident Fibers, Fibex, Knitmasters and business of TexInnovate. To fund the cash component payable at completion, Ecofibre has conducted a placement under its Listing Rule 7.1 capacity to existing institutional shareholders of $29.5 million in aggregate at an issue price of $2.50. Ecofibre intends to employ all of TexInnovate’s staff at completion. Transaction is subject to satisfactory due diligence by Ecofibre over a 30-day period. Transaction is expected to close on September 1, 2020.